TG Branfalt

Millennial and Gen Z shoppers account for the majority of all cannabis sales in the U.S. (63%) and Canada (72.1%), according to recent data from the analytics firm Headset.

New Mexico adult-use cannabis dispensaries sold more than $300 million worth of product during the first year they were permitted.

In a follow-up to the state’s recent cannabis legalization policy, Connecticut’s chief state attorney’s office has dropped 1,562 possession charges as state lawmakers draft legislation to halt cannabis-specific prosecutions moving forward.

A bipartisan proposal by U.S. Sens. John Tester (D-MT) and Mike Braun (R-IN) is seeking to reduce regulations for hemp farmers producing grain and fiber.

Lawmakers in the Missouri House passed a measure last week to mandate studies investigating psilocybin, the psychedelic substance in hallucinogenic mushrooms, as a mental health treatment.

Washington lawmakers have pared the state’s psychedelic therapies proposal down to just a pilot program that would allow some military veterans and first responders to access the treatment.

The NBA has permanently ended the practice of drug testing players for cannabis use, per a tentative Collective Bargaining Agreement with league players.

Kentucky Gov. Andy Beshear (D) last week signed the state’s medical cannabis legalization bill into law; the bill allows patients to access cannabis edibles and concentrates but stops short of permitting smokable products.

Cannabis “gifting” businesses in Washington D.C. may now apply to become medical cannabis dispensaries under a law that took effect last week.

Kentucky lawmakers passed a bill to legalize medical cannabis in the state on Thursday, sending the proposal to Gov. Andy Beshear (D) who said he plans to “proudly” sign the legislation later today.

Lawmakers in the Montana Senate Business, Labor and Economic Affairs Committee voted 6-4 against a proposal that sought to eliminate adult-use cannabis sales in the state.

South Dakota-based 605 Cannabis is suing the state’s Department of Health, alleging regulatory overreach and the improper issuance of violations leading to more than $1 million worth of damages.

A Montana proposal seeks to eliminate the state’s adult-use cannabis dispensaries and raise the medical cannabis tax from 4% to 20%.

A New York Appeals Court judge this week narrowed the injunction blocking the licensing of cannabis dispensaries. The move will let the licensing process move forward except in the state’s Finger Lakes region.

Virginia Gov. Glenn Youngkin (R) is proposing a CBD carveout for a bill that would enact strict regulations on hemp-derived THC products.

The Delaware Senate passed House-approved adult-use cannabis legalization bills yesterday, sending the legislation to Gov. John Carney (D) who vetoed a similar legalization measure last summer.

Vermont regulators recently fined a licensed cultivator $20,000 for product diversion and other violations after he posted a video of himself on Instagram delivering cannabis products to an unlicensed New York City dispensary.

A North Carolina legalization proposal would expunge prior cannabis-related convictions, allow adult home grows of up to six plants, and carry a 20% excise tax on cannabis sales.

Ben & Jerry’s Ice Cream co-founder Ben Cohen announced the launch of Ben’s Best Blnz, or B3, a nonprofit cannabis brand where all proceeds will be used for social benefit.

South Dakota Gov. Kristi Noem (R) has signed a total of eight cannabis-related bills this session.

Montana lawmakers in the House Business and Labor Committee advanced a bill to update the state’s adult-use cannabis regulations.

Pennsylvania’s latest adult-use cannabis legalization proposal would see state-licensed liquor stores control the retail cannabis market.

Lawmakers in Idaho — one of the country’s last remaining holdouts on medical cannabis reforms — may consider a medical cannabis legalization proposal as the year’s legislative session winds down.

A recent study found that 37% of medical cannabis patients in Australia have a legal prescription for the plant, up from just 2.5% in 2018.